Susan Melin to Feasibility Studies
This is a "connection" page, showing publications Susan Melin has written about Feasibility Studies.
Connection Strength
0.026
-
Lawrence JA, Akman SA, Melin SA, Case LD, Schwartz GG. Oral paricalcitol (19-nor-1,25-dihydroxyvitamin D2) in women receiving chemotherapy for metastatic breast cancer: a feasibility trial. . 2013 Jun; 14(6):476-80.
Score: 0.026